STRATA Skin Sciences (NASDAQ:SSKN) Stock Price Passes Above Two Hundred Day Moving Average of $0.93

STRATA Skin Sciences, Inc. (NASDAQ:SSKNGet Rating)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.93 and traded as high as $0.93. STRATA Skin Sciences shares last traded at $0.93, with a volume of 3,454 shares trading hands.

Analyst Ratings Changes

Separately, Oppenheimer decreased their price target on shares of STRATA Skin Sciences to $2.00 in a research note on Tuesday, November 15th.

STRATA Skin Sciences Stock Performance

The stock has a market capitalization of $32.29 million, a P/E ratio of -5.47 and a beta of 1.75. The company has a 50 day simple moving average of $0.85 and a 200-day simple moving average of $0.93. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.32 and a quick ratio of 0.92.

STRATA Skin Sciences (NASDAQ:SSKNGet Rating) last announced its quarterly earnings data on Wednesday, November 9th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. The business had revenue of $9.41 million for the quarter, compared to analysts’ expectations of $8.46 million. STRATA Skin Sciences had a negative return on equity of 26.52% and a negative net margin of 17.86%. On average, equities analysts forecast that STRATA Skin Sciences, Inc. will post -0.2 EPS for the current year.

Institutional Trading of STRATA Skin Sciences

Hedge funds and other institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. bought a new position in STRATA Skin Sciences in the 1st quarter worth approximately $47,000. Creative Planning grew its position in shares of STRATA Skin Sciences by 100.0% in the third quarter. Creative Planning now owns 100,010 shares of the medical device company’s stock valued at $87,000 after purchasing an additional 50,000 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of STRATA Skin Sciences by 8.4% during the 1st quarter. Vanguard Group Inc. now owns 865,578 shares of the medical device company’s stock valued at $1,273,000 after purchasing an additional 67,029 shares during the period. Finally, Essex Investment Management Co. LLC lifted its holdings in STRATA Skin Sciences by 57.2% during the 3rd quarter. Essex Investment Management Co. LLC now owns 419,830 shares of the medical device company’s stock worth $366,000 after purchasing an additional 152,845 shares in the last quarter. Institutional investors own 32.23% of the company’s stock.

STRATA Skin Sciences Company Profile

(Get Rating)

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.

See Also

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.